BlackRock’s Aethlon Medical AEMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8 | Hold |
2
| – | – | ﹤0.01% | 5676 |
|
|
2026
Q1 | $22 | Hold |
2
| – | – | ﹤0.01% | 5647 |
|
|
2025
Q4 | $28 | Hold |
2
| – | – | ﹤0.01% | 5504 |
|
|
2025
Q3 | $71 | Sell |
2
-16
| -89% | -$922 | ﹤0.01% | 5412 |
|
|
2025
Q2 | $1.1K | Hold |
18
| – | – | ﹤0.01% | 5354 |
|
|
2025
Q1 | $2.63K | Hold |
18
| – | – | ﹤0.01% | 5291 |
|
|
2024
Q4 | $6.31K | Hold |
18
| – | – | ﹤0.01% | 5209 |
|
|
2024
Q3 | $3.42K | Hold |
18
| – | – | ﹤0.01% | 5076 |
|
|
2024
Q2 | $3.66K | Hold |
18
| – | – | ﹤0.01% | 5153 |
|
|
2024
Q1 | $12.3K | Hold |
18
| – | – | ﹤0.01% | 5067 |
|
|
2023
Q4 | $16.1K | Hold |
18
| – | – | ﹤0.01% | 5109 |
|
|
2023
Q3 | $16.7K | Hold |
18
| – | – | ﹤0.01% | 5162 |
|
|
2023
Q2 | $26.6K | Hold |
18
| – | – | ﹤0.01% | 5167 |
|
|
2023
Q1 | $28.2K | Hold |
18
| – | – | ﹤0.01% | 5211 |
|
|
2022
Q4 | $20.3K | Hold |
18
| – | – | ﹤0.01% | 5377 |
|
|
2022
Q3 | $43K | Hold |
18
| – | – | ﹤0.01% | 5386 |
|
|
2022
Q2 | $82K | Hold |
18
| – | – | ﹤0.01% | 5289 |
|
|
2022
Q1 | $108K | Hold |
18
| – | – | ﹤0.01% | 5269 |
|
|
2021
Q4 | $138K | Hold |
18
| – | – | ﹤0.01% | 5185 |
|
|
2021
Q3 | $282K | Buy |
18
+16
| +800% | +$269K | ﹤0.01% | 4900 |
|
|
2021
Q2 | $41K | Sell |
2
-1
| -33% | -$11.5K | ﹤0.01% | 5211 |
|
|
2021
Q1 | $21K | Hold |
3
| – | – | ﹤0.01% | 5025 |
|
|
2020
Q4 | $25K | Hold |
3
| – | – | ﹤0.01% | 4753 |
|
|
2020
Q3 | $14K | Buy |
3
+2
| +200% | +$13.5K | ﹤0.01% | 4760 |
|
|
2020
Q2 | $8K | Hold |
1
| – | – | ﹤0.01% | 4801 |
|
|
2020
Q1 | $6K | Hold |
1
| – | – | ﹤0.01% | 4753 |
|
|
2019
Q4 | $3K | Hold |
1
| – | – | ﹤0.01% | 4833 |
|
|
2019
Q3 | $13K | Hold |
1
| – | – | ﹤0.01% | 4691 |
|
|
2019
Q2 | $20K | Hold |
1
| – | – | ﹤0.01% | 4687 |
|
|
2019
Q1 | $53K | Hold |
1
| – | – | ﹤0.01% | 4468 |
|
|
2018
Q4 | $91K | Hold |
1
| – | – | ﹤0.01% | 4370 |
|
|
2018
Q3 | $64K | Hold |
1
| – | – | ﹤0.01% | 4517 |
|
|
2018
Q2 | $69K | Hold |
1
| – | – | ﹤0.01% | 4518 |
|
|
2018
Q1 | $64K | Hold |
1
| – | – | ﹤0.01% | 4407 |
|
|
2017
Q4 | $60K | Hold |
1
| – | – | ﹤0.01% | 4408 |
|
|
2017
Q3 | $81K | Hold |
1
| – | – | ﹤0.01% | 4402 |
|
|
2017
Q2 | $112K | Hold |
1
| – | – | ﹤0.01% | 4382 |
|
|
2017
Q1 | $242K | Buy |
+1
| New | +$232K | ﹤0.01% | 4174 |
|
BlackRock's AEMD Position: Q2 2026 in Review
BlackRock held its Aethlon Medical (AEMD) position steady in Q2 2026 at 2 shares worth $8. The position accounts for ﹤0.01% of the portfolio, ranked #5676.
BlackRock first reported a position in AEMD in Q1 2017 and has held it in 38 quarters since. The position peaked at $282K in Q3 2021. 1 fund tracked by Wall St. Rank holds AEMD as of Q2 2026.
- BlackRock held 2 shares of Aethlon Medical worth $8 as of Q2 2026.
- BlackRock left its Aethlon Medical share count unchanged in Q2 2026.
- Aethlon Medical made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5676 holding.
- BlackRock first reported a position in Aethlon Medical in Q1 2017 and has held it in 38 quarters since.
- BlackRock's Aethlon Medical position peaked at $282K in Q3 2021.
- 1 fund tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.